The Johnson & Johnson coronavirus vaccine has been shown to be 66 per cent effective at preventing moderate to severe illness, according to data from a phase-3 clinical trial.
Johnson & Johnson’s jab could be a lifeline…
The Johnson & Johnson coronavirus vaccine has been shown to be 66 per cent effective at preventing moderate to severe illness, according to data from a phase-3 clinical trial.